Published: 18 October 2014
Author(s): Shankar Kumar, Anand Tana, Anu Shankar
Section: Review Article

Significant improvements in the treatment of cystic fibrosis over the last few decades have altered this lethal disease in children to a multisystem disorder with survival into adult life now common. In most developed countries the numbers of adult cystic fibrosis patients outnumber children. This is mainly due to improvements in care during early life. The principal cause of morbidity and mortality is pulmonary disease, and so the focus of new treatments has targeted the lungs. Identification of the underlying gene defect in the cystic fibrosis transmembrane conductance regulator has ushered in a new era in cystic fibrosis research, with prospects of a cure.


Stay informed on our latest news!


This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.